mbiomics
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.
mbiomics has raised €12M across 1 funding round from 2 investors, most recently a Series A round in Apr 2026. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.
Munich, Germanywww.mbiomics.com ↗
Total raised
€12M
€12,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2026-04
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDmbiomics — funding by year — interactive chart.
Data table
| mbiomics — funding by year | |
|---|---|
| 2026 | €12M |
Signals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Raised very recently
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-30 | Series A | €12M | Bayern Kapital,MIG Fonds | View deal → |
Investors
2Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData